MARATTO

article · Microorganisms

A One Health Perspective on Proteus mirabilis: The Interaction of Virulence and Antimicrobial Resistance Across Human and Animal Reservoirs

20261 citationOpen accessAin Shams University Hospital

Abstract

Proteus mirabilis (P. mirabilis), a common commensal and opportunistic pathogen, circulates freely across interconnected human, animal, and environmental reservoirs, embodying the One Health concept. Its key virulence factors—urease activity, swarming motility, and biofilm formation—drive severe urinary tract infections, particularly catheter-associated ones. These virulence traits concurrently facilitate the acquisition and dissemination of antimicrobial resistance (AMR) via mobile genetic elements, leading to extensively drug-resistant clones. Epidemiological and genomic evidence confirms that identical multidrug-resistant clones and resistance mechanisms (ESBLs, carbapenemases) are shared among human clinical isolates, livestock, food products, and environmental samples. This demonstrates continuous, multi-directional transmission through interconnected zoonotic, foodborne, and environmental pathways. The synergistic convergence of potent virulence and escalating AMR within shared reservoirs heightens public health risks. Effective containment therefore demands integrated One Health strategies: enhanced cross-sectorial surveillance, stringent antimicrobial stewardship, robust infection control, and the creation of novel treatments. A coordinated global response is crucial to curb the spread of resistant P. mirabilis and preserve antibiotic efficacy.

Research topics

  • Antibiotic Resistance in Bacteria
  • Escherichia coli research studies
  • Bacterial biofilms and quorum sensing

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/microorganisms14020444

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.